RESEARCH-USE BIOSIMILAR ANTIBODY
Siltuximab
Monoclonal antibody · IgG1
Siltuximab is an anti-IL-6 (interleukin-6) monoclonal antibody, and shows antitumor activity. Siltuximab can be used in Multicentric Castleman's Disease (MCD) and COVID-19 research.
TARGETCentocor Inc
YMonoclonal antibody
TARGETJanssen Biotech
CATALOG NUMBERSC-BS-181
MOLECULAR WEIGHTApprox. 144.98 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Siltuximab is an anti-IL-6 (interleukin-6) monoclonal antibody, and shows antitumor activity. Siltuximab can be used in Multicentric Castleman's Disease (MCD) and COVID-19 research.
Siltuximab is a recombinant research-use antibody directed against Centocor Inc / Janssen Biotech.